---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-24-000017"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T23:03:45.696474+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics appoints Thomas Dubin to Board, restores Audit Committee compliance

## Summary
- Thomas I. H. Dubin appointed as Class I director, expanding Board from 4 to 5 members.
- Dubin will serve on Audit Committee, restoring Nasdaq compliance after Daniel Donovan's resignation.
- Granted options to purchase 50,000 shares at $4.42 per share, vesting in four equal installments.
- Dubin brings deep experience from Alexion Pharmaceuticals (former chief legal officer) and other biotech roles.
- Four of five Board members are now independent per Nasdaq standards.

## SEC filing metadata
- accession: 0001567264-24-000017
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000017/0001567264-24-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000017/intensity-20240514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-24-000017
- JSON: https://secwatch.observer/filing/0001567264-24-000017.json
- Plain text: https://secwatch.observer/filing/0001567264-24-000017.txt

## Key facts
- Executive change
  Thomas I. H. Dubin was appointed as Class I director at INTENSITY THERAPEUTICS, INC..
  - Action: appointed
  - Role: Class I director
  source text: appointed Thomas I. H. Dubin to the Board as a Class I director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567264/000156726424000017/0001567264-24-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.